Clinical trial
Melatonin in Alzheimer's Disease: Effect on Disease Progression and Epileptiform Activity.
NCT04522960 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Melatonin in Alzheimer's Disease: Effect on Disease Progression and Epileptiform Activity.
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 20, 2020
- Completion date
- July 31, 2023
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.